Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fast, Efficient High Performance Ion Mobility Spectrometry Proves a Compelling PAT for Pharma

Excellims showcases GMP-Compliant at-line instrumentation tailored to pharmaceutical applications.


News provided by

Excellims Corporation

Jul 21, 2021, 06:00 ET

Share this article

Share toX

Share this article

Share toX


ACTON, Mass., July 21, 2021 /PRNewswire-PRWeb/ -- Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (High Performance IMS) and Compact Ion Mobility Mass Spectrometry (MS), signals its commitment to the pharmaceutical industry with the introduction of GMP-compliant at-line PAT (process analytical technology) and an increasing body of literature demonstrating its value in pharmaceutical applications. Despite its success in security applications, IMS is currently under-utilized by the pharmaceutical industry. Excellims has harnessed the inherent advantages of IMS in high-performance instrumentation that brings fast, GMP-compliant analyses at-line, to the point of need, creating a PAT well-suited to applications ranging from reaction monitoring to cleaning validation.

High performance IMS is particularly suited to cleaning validation, offering sensitivity and speed. A regulatory requirement (FDA CFR - Code of Federal Regulations Title 21, Sec. 211.67), cleaning validation requires that all manufacturing equipment is free from contamination to ensure the safety, identity, strength, quality, or purity of the drug product. Legacy analytical techniques (such as total organic carbon (TOC) and high performance liquid chromatography HPLC) can be lengthy and/or lab-based, keeping production equipment offline for too long. This has driven the desire for more responsive at-line or near-line technologies.

Excellims has harnessed the inherent advantages of IMS in high-performance instrumentation that brings fast, GMP-compliant analyses at-line, to the point of need, creating a PAT well-suited to applications ranging from reaction monitoring to cleaning validation.

Post this

HPIMS (high-performance ion mobility spectrometry) achieves chemical separation with high resolving power (R > 70) and sensitivity while only needing 30 seconds for a typical analysis. Combined with electrospray ionization, HPIMS can detect and quantify a wide range of analytes, including isobaric compounds, without a need for complex column selection or non-traditional detectors. Liberated from the vacuum hood, HPIMS can be deployed at the point of need and presents a fast alternative for many applications typically addressed by chromatography.

"Pharma is a natural home for IMS", observes Dr Ching Wu, Founder and CEO of Excellims. "And we are excited to reaffirm our commitment to this industry. We recognized early the potential for high performance IMS to answer requirements for PAT directly. While many traditional analytical techniques are lab-based with long measurement times or instrumentation too cumbersome for in-field measurement, HPIMS is inherently well-suited to point of need implementation. Our HPIMS technology brings close to real-time measurement, with the sensitivity pharma requires, right to the manufacturing line."

Excellims offers three HPIMS-based instruments: The first, the GA2200, provides IMS-based chemical detection at the point of need, in minutes, rather than the days associated with lab-based techniques and is the only standalone HPIMS designed for the GMP environment. The second is a rugged, portable integrated HPIMS-mass spectrometer (MC3100), that brings two-dimensional chemical detection to address unmet field detection challenges. Finally, Excillims also enables ion mobility to be added to a lab for six figures, rather than seven using the MA3100, a HPIMS module that can be added to an existing mass spectrometer.

Download more in this whitepaper on IMS for PAT, or explore the webinar "Establishing a rapid, compliant, specific cleaning validation protocol," date soon to be announced.

About Excellims:

Founded in 2005, Excellims Corporation is the world innovator in ion mobility solutions for chemical detection. We provide high speed chemical analysis solutions for use in:

  • Chemical & Pharmaceutical
  • Food and Drug Safety
  • Security and Forensic
  • Medical Diagnostics

Excellims developed high performance ion mobility spectrometry (HPIMS) to address the needs of government and industry as they search for better ways of detecting chemical substances with increasing speed and accuracy.

Our analytical tools perform simultaneous separation and detection. Excellims instruments are based on our core technology, high performance ion mobility spectrometry (HPIMS) and HPIMS-MS. HPIMS is well suited for applications requiring robust analysis that need to be performed in challenging environments.

We offer the world's first ESI-HPIMS (DirectsprayTM) systems for liquids that deliver chromatography like separation with simultaneous detection. Quick to change source options add versatility for liquid, solid or gas samples.

We manufacture an entire family of chemical analysis and detection products for research, industry and government.

http://www.excellims.com
LinkedIn

For media enquiries in the USA
Laura Browne
[email protected]
+1 978 893 9618

For media enquiries in Europe
Contact:
Claire England
[email protected]
+44 (0) 7808 020554

Media Contact

Lexi Chapin, Excellims Corporation, +1 7819573130 Ext: 6, [email protected]

Twitter

SOURCE Excellims Corporation

Related Links

http://www.excellims.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.